Endocannabinoids and Metabolic Disorders
- PMID: 26408168
- DOI: 10.1007/978-3-319-20825-1_13
Endocannabinoids and Metabolic Disorders
Abstract
The endocannabinoid system (ECS) is known to exert regulatory control on essentially every aspect related to the search for, and the intake, metabolism and storage of calories, and consequently it represents a potential pharmacotherapeutic target for obesity, diabetes and eating disorders. While the clinical use of the first generation of cannabinoid type 1 (CB(1)) receptor blockers has been halted due to the psychiatric side effects that their use occasioned, recent research in animals and humans has provided new knowledge on the mechanisms of actions of the ECS in the regulation of eating behavior, energy balance, and metabolism. In this review, we discuss these recent advances and how they may allow targeting the ECS in a more specific and selective manner for the future development of therapies against obesity, metabolic syndrome, and eating disorders.
Keywords: CB1 receptor; CB2 receptor; Eating disorder; Endocannabinoid; Metabolic disorder; Obesity.
Similar articles
-
New insights on the role of the endocannabinoid system in the regulation of energy balance.Int J Obes (Lond). 2016 Feb;40(2):210-9. doi: 10.1038/ijo.2015.179. Epub 2015 Sep 16. Int J Obes (Lond). 2016. PMID: 26374449 Review.
-
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders.Expert Opin Investig Drugs. 2012 Sep;21(9):1309-22. doi: 10.1517/13543784.2012.704019. Epub 2012 Jul 11. Expert Opin Investig Drugs. 2012. PMID: 22780328 Review.
-
MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.Eur J Endocrinol. 2017 Jun;176(6):R309-R324. doi: 10.1530/EJE-16-1044. Epub 2017 Feb 28. Eur J Endocrinol. 2017. PMID: 28246151 Review.
-
The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders.Cell Metab. 2013 Apr 2;17(4):475-90. doi: 10.1016/j.cmet.2013.03.001. Cell Metab. 2013. PMID: 23562074 Review.
-
The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?Pharmacol Biochem Behav. 2010 Jun;95(4):375-82. doi: 10.1016/j.pbb.2010.03.012. Epub 2010 Mar 27. Pharmacol Biochem Behav. 2010. PMID: 20347862 Review.
Cited by
-
Effects of Full-Spectrum Cannabis Oil with a Cannabidiol:Tetrahydrocannabinol 2:1 Ratio on the Mechanisms Involved in Hepatic Steatosis and Oxidative Stress in Rats Fed a Sucrose-Rich Diet.Med Cannabis Cannabinoids. 2023 Nov 15;6(1):170-183. doi: 10.1159/000534610. eCollection 2023 Jan-Dec. Med Cannabis Cannabinoids. 2023. PMID: 38023489 Free PMC article.
-
Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice.Front Pharmacol. 2017 Oct 5;8:707. doi: 10.3389/fphar.2017.00707. eCollection 2017. Front Pharmacol. 2017. PMID: 29051736 Free PMC article.
-
Combined ∆9-tetrahydrocannabinol and moderate alcohol administration: effects on ingestive behaviors in adolescent male rats.Psychopharmacology (Berl). 2019 Feb;236(2):671-684. doi: 10.1007/s00213-018-5093-3. Epub 2018 Nov 10. Psychopharmacology (Berl). 2019. PMID: 30415276 Free PMC article.
-
Effects of a High-Protein/Moderate-Carbohydrate Diet on Appetite, Gut Peptides, and Endocannabinoids-A Preview Study.Nutrients. 2019 Sep 21;11(10):2269. doi: 10.3390/nu11102269. Nutrients. 2019. PMID: 31546629 Free PMC article.
-
Hypothalamic miR-219 regulates individual metabolic differences in response to diet-induced weight cycling.Mol Metab. 2018 Mar;9:176-186. doi: 10.1016/j.molmet.2018.01.015. Epub 2018 Feb 2. Mol Metab. 2018. PMID: 29398616 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
